DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more
Drugs by Name Drugs by Condition Drugs by Category Most Searched Ratings/Reviews Active Ingred's Alerts Adverse Events

Rabavert (Rabies Vaccine Flury LEP) - Summary

Rabavert Rx
Summary Description Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage and Contraindications Clinical Pharmacology Other Rx Information
 

Rabavert News
News in Media Published Studies Curr't Clinical Trials


Nutrilib.com
A comprihensive source of nutritional information

RABAVERT SUMMARY

RabAvert® Rabies Vaccine produced by Chiron Behring GmbH & Co KG is a sterile freeze-dried vaccine obtained by growing the fixed-virus strain Flury LEP in primary cultures of chicken fibroblasts.

RabAvert® is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups.


See all Rabavert indications & dosage >>

RABAVERT NEWS HIGHLIGHTS

Published Studies Related to Rabavert (Rabies Vaccine Flury LEP)

Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005. [2007.05.22]

more >>

Clinical Trials Related to Rabavert (Rabies Vaccine Flury LEP)

Phase 2 FMP2.1 Trial in Mali [Active, not recruiting]

Phase 1 Trial of a Malaria Vaccine in Young Kenyan Children [Completed]

more >>
Page last updated: 2008-01-02

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008